American Healthcare REIT Announces New 14M Share Forward Sale Offering

summarizeSummary

American Healthcare REIT announced a new offering of 14 million shares (up to 16.1 million with option) through a forward sale agreement, which will result in significant dilution for existing shareholders as the company defers receiving proceeds for up to 24 months.

check_boxKey Events

• New Equity Offering Launched

  American Healthcare REIT announced a new offering of 14,000,000 shares of common stock, with an option for underwriters to purchase an additional 2,100,000 shares.

• Forward Sale Agreement Structure

  The offering is structured as a forward sale agreement, where a forward purchaser sells shares to the underwriter now, but the company will receive proceeds upon physical settlement within approximately 24 months. The company will not receive proceeds from the initial sale.

• Significant Potential Dilution

  This offering represents a potential dilution of 7.26% (or 8.35% if the option is fully exercised) based on current outstanding shares. This is in addition to 12.2 million shares already under unsettled forward sale agreements, bringing total potential dilution from forward sales to nearly 15%.

• Proceeds for Future Investments

  The net proceeds from the settlement of the forward sale agreement are expected to be used for general corporate purposes, including potential future investments.

auto_awesomeAnalysis

This filing details a new equity offering of 14 million shares (potentially 16.1 million with the over-allotment option) through a forward sale agreement. While the company will not receive immediate proceeds from the initial sale by the forward purchaser, it expects to receive cash upon physical settlement within 24 months. This offering, valued at approximately $711 million (or $818 million with the option) based on the prior day's closing price, represents a significant potential dilution of 7.26% to 8.35% of current outstanding shares. This is in addition to 12.2 million shares already under unsettled forward sale agreements. The proceeds are earmarked for general corporate purposes, including potential future investments, following the company's recent strong Q1 2026 financial performance and raised guidance. The structure defers cash inflow to the company but creates an immediate overhang and dilution for existing shareholders.